Biologics Spine Top Stories Altus Spine and Joint Pain Center Partners with Regenexx to Bring Revolutionary Non-Surgical Pain Management to the Rio Grande Valley byTim AllenSeptember 30, 2024
Biologics Spine BioRestorative Therapies Enters Agreement with Regenexx, Granting BRTX Exclusive License Rights for Intellectual Property Related to the Development and Commercialization of its BRTX-100® Disc Program to Treat Chronic Lumbar Disc Disease byChris StewartDecember 5, 2022
Biologics Regenexx Publishes Mid-term Results of Its Randomized Controlled Trial Showing Its Perc-ACLR Procedure Can Help Patients Avoid Surgical ACL Reconstruction byChris StewartAugust 10, 2022
Biologics Published Regenexx Research, Involving Stem Cells And Platelets, Shows Promise For Treating Osteoarthritis Of The Knee byJosh SandbergDecember 21, 2018
Biologics Regenexx Publishes New Research Findings That May Help Alleviate the Opioid Crisis byJosh SandbergJanuary 16, 2018
Biologics Top Stories Regenexx Announces Successful Merger with Harbor View Medical byJosh SandbergJuly 12, 2017
Spine Reports of the Death of the C1-C2 Facet Injection have Been Greatly Exaggerated byJosh SandbergApril 18, 2017
Biologics Regenexx Network Using Regenerative Medicine Technologies in Interventional Orthopedics to Treat Pain byJosh SandbergApril 17, 2017
Hospitals Regenexx® Announces Issue of United States Patent on Proprietary Orthopedic Stem Cell Procedure byJosh SandbergNovember 2, 2015
